Analyst Ratings for Phathom Pharmaceuticals (PHAT)
PHAT Rating Summary
PHAT Price Target Summary
- Highest: $29.00 (Cantor Fitzgerald)
- Lowest: $16.00 (Barclays)
- Average: $24.86
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$24.86 (+133%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 87%
Avg. $ Target:
$24.86 (+133%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/12/2025 | Raymond James | Martin Auster | New Coverage | Strong Buy (N/A) |
28.00 (N/A) |
14.55 (10.67) |
-26.67% | Details |
| 12/9/2025 | Barclays | Glen Santangelo | New Coverage | Equalweight (N/A) |
16.00 (N/A) |
14.58 (10.67) |
-26.82% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
